Characterizing the Tumor Response to Treatment With Combretastatin A4 Phosphate
- 1 May 2007
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 68 (1), 211-217
- https://doi.org/10.1016/j.ijrobp.2006.12.051
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Disrupting tumour blood vesselsNature Reviews Cancer, 2005
- Phase I Trial of Combretastatin A-4 Phosphate with CarboplatinClinical Cancer Research, 2005
- Vascular‐targeting therapies for treatment of malignant diseaseCancer, 2004
- Combretastatin family member OXI4503 induces tumor vascular collapse through the induction of endothelial apoptosisInternational Journal of Cancer, 2004
- Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in TumorsThe American Journal of Pathology, 2003
- Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in TumorsThe American Journal of Pathology, 2002
- The biology of the combretastatins as tumour vascular targeting agentsInternational Journal of Experimental Pathology, 2002
- Openings between Defective Endothelial Cells Explain Tumor Vessel LeakinessThe American Journal of Pathology, 2000
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaThe New England Journal of Medicine, 1991
- Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesisMicrovascular Research, 1977